Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Desai
    Member
    • Dec 2013
    • 18

    #1

    Ngs

    Dear Friends,

    I am newbie in sequencing field. I have some questions in my mind.
    (1) Why we prefer illumina more than 454 sequencing, when 454 gives
    400bp reads length compare to ilumina which gives only 150 reads length?
    (2) And a silly question, what does mean 2*150 or 1 * 250 ? I mean what is 1 or 2
    stand for. Is is for single and pair?
    Thank you in advance for answer or just view.
  • lethalfang
    Member
    • Aug 2011
    • 95

    #2
    Originally posted by Desai View Post
    Dear Friends,

    I am newbie in sequencing field. I have some questions in my mind.
    (1) Why we prefer illumina more than 454 sequencing, when 454 gives
    400bp reads length compare to ilumina which gives only 150 reads length?
    (2) And a silly question, what does mean 2*150 or 1 * 250 ? I mean what is 1 or 2
    stand for. Is is for single and pair?
    Thank you in advance for answer or just view.
    1) Direct comparison of Illumina and 454: http://www.plosone.org/article/info%...l.pone.0030087

    2) I think it means paired end (2 x 150) vs. single read (1 x 150).

    Comment

    • AllSeq
      Registered Vendor
      • Oct 2013
      • 138

      #3
      Originally posted by Desai View Post
      Dear Friends,

      I am newbie in sequencing field. I have some questions in my mind.
      (1) Why we prefer illumina more than 454 sequencing, when 454 gives
      400bp reads length compare to ilumina which gives only 150 reads length?
      (2) And a silly question, what does mean 2*150 or 1 * 250 ? I mean what is 1 or 2
      stand for. Is is for single and pair?
      Thank you in advance for answer or just view.
      454 actually does a bit better than 400b reads - some users are able to produce close to 1000b reads. Even though Illumina has shorter reads (up to 2X300 on the MiSeq), it beat out 454 for one simple reason - price. Illumina's platforms generate data at a cost of about 1/100th what it would cost to generate on the 454. Roche simply didn't improve their system as fast as the other platforms (Illumina, Ion Torrent and even PacBio). As such, they've made the decision to shut down the platform in 2016.

      You can learn more about the performance specs and costs of the various platforms on our NGS Knowledge Bank.
      AllSeq - The Sequencing Marketplace
      [email protected]
      www.AllSeq.com

      Comment

      • Desai
        Member
        • Dec 2013
        • 18

        #4
        I got your point. I thought it related to quality means illumina gave better quality than Roche 454.

        Comment

        • AllSeq
          Registered Vendor
          • Oct 2013
          • 138

          #5
          Originally posted by Desai View Post
          I got your point. I thought it related to quality means illumina gave better quality than Roche 454.
          454 has decent quality, but it definitely has a homopolymer issue - strings of the same base are challenging for the detection system to get right, leading to indel errors. Ion Torrent suffers from the same issue (due to similar chemistries), but they've done more to correct it.
          AllSeq - The Sequencing Marketplace
          [email protected]
          www.AllSeq.com

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
            by SEQadmin2



            CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

            Despite this, “CRISPR helped turn genome editing from a specialized technique into
            ...
            07-31-2026, 11:01 AM
          • SEQadmin2
            Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
            by SEQadmin2


            Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

            The systematic characterization of the human proteome has
            ...
            07-20-2026, 11:48 AM
          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            07-09-2026, 11:10 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 08-03-2026, 10:13 AM
          0 responses
          21 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-31-2026, 02:55 AM
          0 responses
          34 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-24-2026, 12:17 PM
          0 responses
          25 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-23-2026, 11:41 AM
          0 responses
          21 views
          0 reactions
          Last Post SEQadmin2  
          Working...